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Cytoplasmic prionpresent in the cytosol of some neurons and non-neuronal cells and that the N-
terminal signal peptide is slightly inefﬁcient has brought speculations concerning a possible function of the
protein in the cytosol. Here, we show that cells expressing a cytosolic form of PrP termed cyPrP display a
large juxtanuclear cytoplasmic RNA organelle. Although cyPrP spontaneously forms aggresomes, we used
several mutants to demonstrate that the assembly of this RNA organelle is independent from cyPrP
aggregation. Components of the organelle fall into three classes: mRNAs; proteins, including the RNAseIII
family polymerase Dicer, the decapping enzyme Dcp1a, the DEAD-box RNA helicase DDX6, and the small
nuclear ribonucleoprotein-associated proteins SmB/B′/N; and non-coding RNAs, including rRNA 5S, tRNAs,
U1 small nuclear RNA, and microRNAs. This composition is similar to RNA granules or chromatoid bodies
from germ cells, or planarian stem cells and neurons, which are large ribonucleoprotein complexes predicted
to function in RNA processing and posttranscriptional gene regulation. The domain of PrP encompassing
residues 30 to 49 is essential for the formation of the RNA particle. Our ﬁndings conﬁrm the intriguing
relation between PrP and RNA in cells, and underscore an unexpected function for cytosolic PrP: assembling a
large RNA processing center which we have termed PrP-RNP for PrP-induced ribonucleoprotein particle.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Prion diseases are a group of transmissible neurodegenerative
disorders including Creutzfeldt–Jakob disease (CJD) and Gerstmann–
Sträussler–Scheinker syndrome (GSS) in humans, scrapie in sheep and
goat, bovine spongiform encephalopathy (BSE) in cattle and chronic
wasting disease (CWD) in deer. A common hallmark of prion diseases
is the conversion of the cellular prion protein PrPC into PrPSc, a
misfolded and proteinase K (PK)-resistant isoform, which is the main
component of infectious prions [1–3].
PrPC is primarily a plasma membrane GPI-anchored glycoprotein
localized in specialized domains known as lipid rafts [4]. However,
besides the major membrane-bound form, PrPC may also be found in
transmembrane forms [5,6]. One form, termed CtmPrP, has the COOH-
terminus in the ER lumen and the NH2-terminus in the cytosol. The
other transmembrane form, termed NtmPrP, has the opposite orienta-
tion. Both transmembrane forms appear to span the membrane at then genetically fused to EGFP;
n ﬂuorescent protein; miRNA,
d RiboNucleoprotein Particle;
roteins B/B′/N
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ucou).
l rights reserved.same hydrophobic domain comprised between residues 110 and 135
[7]. Interestingly, progressive neurodegeneration both in GSS syn-
drome patients with an A117V mutation and in transgenic mice
carrying a triple mutation within the hydrophobic domain has been
shown to coincide with increased synthesis of CtmPrP [7,8].
The presence of PrPC was also detected in the cytoplasm of
different cell types in physiological conditions. PrPC is present in the
cytosol in subpopulations of neurons in the hippocampus, neocortex,
and thalamus of mice [9]. PrPC is abundantly expressed in the
cytoplasm of beta-pancreatic cells from rats and its levels increase in
response to hyperglycemia or during normal aging [10]. Hypoxia
induces the expression of a GPI-anchorless splice variant of PrP
located in the cytosol of a human glioblastoma cell line [11]. This
cytosolic variant is also detected in human brains and in non-neuronal
tissues [11]. Finally, PrPC is also associated with the sperm cytoplasmic
droplets [12]. All together, these results point to a possible role of PrP
in the cytoplasm. This hypothesis is supported by the observation that
about 20% of PrP never translocates into the ER due to a particularly
inefﬁcient ER translocation signal [13].
Based on previous studies, a cytosolic population of PrP would
seem disadvantageous since expression of a recombinant PrP without
an ER translocation signal is toxic in transgenic animals [14]. This form
of PrP is termed cyPrP for clarity purposes. The toxicity of cyPrP in
cultured cells is controversial with studies arguing in favour of a
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cerebellar cells appeared to be affected in transgenic mice expressing
cyPrP [14], suggesting that toxicity may be cell-type dependent.
Recently, we have shown that cells expressing cyPrP sponta-
neously form PrP aggresomes [19]. Aggresomes are perinuclear
organelles where aggregated proteins are centralised. In contrast to
other proteins forming aggresomes in cultured cells, PrP aggresomes
speciﬁcally induce the co-aggregation of mRNAs [20]. Pull down
assays using oligo-dT cellulose showed that cyPrP co-puriﬁes with
mRNA, indicating that PrP aggresomes are mRNA ribonucleoprotein
complexes. In the present study, we have investigated further the
relationship between cyPrP and RNA. In addition to mRNA, cyPrP
induced the aggregation of various RNAmolecules, including U1 small
nuclear RNA, 5S ribosomal RNA, and tRNA. In contrast, the distribution
of 18S and 28S rRNAs was unchanged. We mapped the RNA
aggregation determinant in the N-terminal unstructured domain of
PrP. A C-terminal truncated mutant of cyPrP containing the unstruc-
tured region of PrP (residues 23–124) and unable to form aggresomes
still induced the assembly of a perinuclear RNA organelle. This RNAFig. 1. Localization of mRNA, 5S rRNA, U1 snRNA, tRNA, 18S and 28S rRNAs in cells expressing
oligo(dT) probe to detect mRNAs with a polyA tail (A), or biotin-labelled nucleotide probes s
were either mock-transfected, transfected with CyPrPEGFP, GFP-250, CyPrPEGFP124stop (124 s
alexa568-labelled streptavidin (red), and nuclei were stained with Hoechst (blue). Red an
(bottom panels). White arrows indicate the formation of RNA aggregates. Scale bar: 5 μm. Oorganelle shares all characteristics of protein aggresomes, including
the assembly of a cage of vimentin surrounding the organelle, its
localization at the centrosome, and the clustering of mitochondria
within the organelle. We used several protein andmicro-RNAmarkers
to demonstrate that this RNA organelle is similar to chromatoid bodies
from germ-cells, and planarians stem cells and neurons. For clarity
purposes, this RNA organelle is termed PrP-RNP for PrP-induced
ribonucleoprotein particle. These results reveal a possible function for
PrP in the cytoplasm: assembling a speciﬁc RNA platform for the
storing and processing of RNA.
2. Experimental procedures
2.1. Antibodies, clones, and reagents
Primary antibodies used were monoclonal anti-Dicer (Abcam,
clone 13D6), anti-DDX6 (Abcam, polyclonal 40684), anti-Dcp1a
(Abnova, clone 3G4), anti-SmB/B′/N (SantaCruz, polyclonal FL-240),
and anti-vimentin (Abcam, clone VI-10 or polyclonal 45939).different protein constructs. In situ hybridizationwas performed with a biotin-labelled
peciﬁc for 5S rRNA (B), U1 snRNA (C), tRNA (D), 18S rRNA (E), or 28S rRNA (F). N2a cells
top), or CyPrPEGFP124–230 (124–230), as indicated. RNA molecules were revealed with
d blue channels are shown merged (top panels), and merged with the green channel
riginal magniﬁcation ×90.
Fig. 1 (continued).
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ins (nup358, nup214/CAN, nup153, nup98, and p62), was purchased
from Abcam. Monoclonal SAF32 was purchased from Cayman. Anti-
VASA/MVH antibody was a kind gift from Dr Kimmins (McGill
University, Montreal, Canada). Secondary antibodies were Alexa
Fluor 633 or 568 F(ab′)2 fragment of goat anti-mouse IgG (Invitrogen).
Cloning of CyPrPEGFP, CyPrPEGFP124stop, and CyPrPEGFP124–230 in
pCEP4β (Invitrogen) was described previously [19]. CyPrP50–230 was
ampliﬁed by PCR using forward 5′-cctctcgagctccacctcagggcggtg-3′
and reverse 5′-cgcggatcctcacgatcctctctggtaataggcctg-3′ primers. The
PCR product was introduced in the HindIII and BamHI restriction sites
of EGFP-pCEP4β [19], to generate CyPrPEGFP50–230. CyPrPEGFP33–230
was ampliﬁed from CyPrPEGFP by PCR using forward 5′-cccaagcttat-
gaacactgggggcagccgatac-3′ and reverse 5′-cgcggatcctcacgatcctctct-
ggtaataggcctg-3′ primers. The PCR product was introduced in the
HindIII and BamHI restriction sites of pCEP4β. CyPrPEGFPΔ30-49 was
generated from CyPrPEGFP by using the Stratagene Quick Change
mutagenesis protocol and the two primers 5′-cgcccgaagcctggag-
gatggggcaaccgctacccacctcagggc-3′ and 5′-gccctgaggtgggtagcggttgccc-
catcctccaggcttcgggcg-3′. Primers were purchased from IDT. All
constructs were sequenced in both orientations.
All reagents were obtained from Sigma-Aldrich, unless otherwise
stated.2.2. Cell culture, transfections, squash preparations
Mouse N2a neuroblastoma were maintained in Dulbecco's mod-
iﬁed Eagle's medium plus 10% fetal bovine serum (Wisent). Transfec-
tions were carried out using Exgen according to the manufacturer's
protocol (MBI Fermentas).
Testes of adult wild-type C57BL/6 mice were decapsulated in PBS
and squash preparations of seminiferous tubules were done as
described in [21].
2.3. Immunoprecipitation and western blotting
Cells (106 in 6-well plates) were rinsed twice with 2 ml cold PBS,
and lysed with 200 μl buffer A [50 mM Tris–HCl, pH 7.5; 150 mM KCl;
1% NP-40; 1 mM EDTA; 0.5 mM DTT; 1 mini EDTA-free protease
inhibitor tablet (Roche) per 10 ml] for 15 min on ice. The lysate was
centrifuged at 10,000 ×g for 10 min at 4 °C. Twenty μl were kept aside
(total input), and the remaining 180 μl were processed for immuno-
precipitation. Protein A/G-PLUS-agarose beads (SantaCruz) were
mixed for 2 h with 10 μl of anti-vimentin or control isotype antibodies.
The antibody-beadmix was thenwashed with buffer NT2 (50 mM Tris
[pH 7.4]; 150 mM NaCl; 1 mM MgCl2; 0.05% Nonindet P-40).
Immunoprecipitation was carried out for 12 h at 4 °C. The beads
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proteins eluted by incubating for 5 min at 95 °C in SDS-PAGE sample
buffer [0.5% SDS (w/v), 1.25% 2-mercaptoethanol (v/v), 4% glycerol
(v/v), 0.01% bromphenol blue (w/v), 15 mM Tris–HCl, pH 6.8]. Proteins
were detected by western blot using anti-Dicer (1/100), anti-DDX6
(1/1000), anti-Dcp1a (1/500), and anti-SmB/B′/N (1/200) antibodies.
2.4. Immunoﬂuorescence, ﬂuorescence in situ hybridization
Cells grown on coverslips were ﬁxed and processed for immuno-
ﬂuorescence as previously described [19]. Primary antibodies dilu-
tions were as followed: Dcp1 (1/100), DDX6 (1/100), Dicer (1/100),
SmB/B′/N (1/50), VASA/MVH (1/200). Secondary antibodies were
diluted 1/1000.
For in situ staining, permeabilized cellswere incubated 10minwith
2 × SSC, andhybridizedwith1 nMof an end-labelled biotinylated probes
overnight at 10 °C below the Tm in the hybridization mixture (2 × SSC,
1 mg/ml yeast tRNA, 10% dextran sulphate, 25% formamide). Probes
were speciﬁc for mRNAs (oligo-dT20),U1 (5′-aaaaccaccttcgtgatcatgg-
tatctcccc-3′), 5S rRNA (5′-tattcccaggcggtctcccatccaagtactaac-3′), 18S
rRNA (5′-atatacgctattggagctggaattacc-3′), 28S rRNA (5′-agtgggtgaacaatc-
caacgcttgg-3′), let-7a (5′-aactatacaacctactacctca-3′), miR21 (5′-tcaacat-
cagtctgataagcta-3′), miR122a (5′-caaacaccattgtcacactcca-3′), and tRNA-
Leu-CAG (5′-aagtccagcgtcagagggga-3′). tRNA-Leu-CAG was chosen
because it is themost abundant in cells. All of the probeswere purchased
from IDT. After washing twicewith 2 × SSC and oncewith 0.5 × SSC, cells
were equilibrated in 1 × PBS containing 1 mg/ml BSA. Cells were
incubatedwith 2 μg/ml Alexa Fluor 633-labelled streptavidin (Molecular
Probes) in 1 × PBS containing 1 mg/ml BSA. After a 1 h incubation, cells
were washed and mounted as previously described [10].Fig. 2. The domain located between residues 30 and 49 is necessary for the assembly of PrP
represented. Numbers indicate residues at the junction of different structural domains (adap
was evaluated by in situ hybridization with a biotin-labelled oligo(dT) probe and alexa568-la
and blue channels are shown merged (left panels), and merged with the green channel (righIn the in situ staining protocol of squash preparations, the
hybridization mixture contained 0.2 mg/ml BSA.
2.5. Microscopy
For epiﬂuorescence analysis, cells were examined with an Eclipse
TE2000-E visible/epiﬂuorescence inverted microscope (Nikon Cor-
poration, Japan) equipped with band pass ﬁlters for ﬂuorescence of
Hoechst (Ex. D340/40: Em. D420), GFP (Ex. D450/40: Em. D500/50)
and tetramethylrhodamine isothiocyanate (TRITC) (Ex. D528/25: Em.
D590/60) (NikonCorporation). Photomicrographs of 1344×1024pixels
were captured using either 60× or 100× oil immersion objectives and
Orca cooled color digital camera (Hamamatsu Photonics, Japan).
Images were processed using NIS Elements AR software (Nikon
Corporation). Within the same ﬁgure, all pictures were takenwith the
same exposure time.
For confocal analysis, cells were examined with a scanning
confocal microscope (FV1000, Olympus, Tokyo, Japan) coupled to an
inverted microscope with a 63× oil immersion objective (Olympus).
Specimens were laser-excited at 488 nm (40 mW Argon laser) and
633 nm (Helium–Neon laser). In order to avoid cross-talk between the
emitted EGFP and Alexa Fluor 633 ﬂuorescences were collected
sequentially at wavelengths 525–550 and N590 nm respectively. Serial
horizontal optical sections of 512×512 pixels with 2 times line
averaging were taken at 0.11 μm intervals through the entire thickness
of the cell (optical resolution: lateral −0.18 μm; axial −0.25 μm).
Images were acquired during the same day, typically from 5 cells of
similar size from each experimental condition using identical settings
of the instrument. For illustration purposes images were pseudoco-
lored according to their original ﬂuorochromes, merged (FluoView-RNP. Diagrams of CyPrPEGFP and several deletion mutants engineered in this study are
ted from [51]). Black box represents EGFP coding sequence. The formation of PrP-RNPs
belled streptavidin to detect mRNAs (red). Nuclei were stained with Hoechst (blue). Red
t panels). White arrows indicate PrP-RNPs. Scale bar: 10 μm. Original magniﬁcation ×90.
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software, Adobe Systems, Mountain View, CA).
3. Results
3.1. Co-aggregation of 5S, U1, tRNA but not 18S and 28S with
PrP aggresomes
The observation that mRNAs aggregate with PrP aggresomes
prompted us to investigate the speciﬁcity of this co-aggregation [20].
We performed ﬂuorescence in situ hybridization (FISH) using probesFig. 3. Aggresomal characteristics of PrP-RNPs. Confocal analysis of γ-tubulin (A), vimentin (
with CyPrPEGFP124stop (green channel), as indicated. PrP-RNPs (white arrows) were detecte
streptavidin (red). Red and cyan channels are shownmerged. N, nucleus. Empty arrows indic
(D) Distribution of mRNA in cells incubated for 12 h in the presence of nocodazole (10 μg/ml)
Scale bar: 5 μm. Original magniﬁcation ×60.speciﬁc for various RNA molecules, including ribosomal 5S, 18S, and
28S RNAs, the small nuclear U1 RNA, and tRNAs. Fluorescent PrP
aggresomes were reconstituted by expressing cyPrPEGFP in murine
neuroblastoma N2a cells [19,20]. The analysis on N2a cells expressing
cyPrPEGFP revealed a concentration of mRNA, 5S, U1, and tRNA with
PrP aggresomes (Fig. 1A–D). In contrast, 18S and 28S rRNAs did not co-
aggregatewith PrP aggresomes, but remained diffuse in the cytoplasm
and the nucleoli (Fig. 1E, F). Previously, we showed that aggregation of
mRNAs was speciﬁc to PrP aggresomes since the aggresome-forming
protein GFP-250 used as a model to study the dynamics of protein
aggresomes did not display anymRNA clustering activity [20] (Fig.1A).B), and mtHSP70 (C) (cyan channel) in mock-transfected N2a cells or in cells transfected
d by in situ hybridization with a biotin-labelled oligo(dT) probe and alexa633-labelled
ate the centrosome (A), the cage of vimentin (B), and the clustering of mitochondria (C).
. Cells were transfected with CyPrPEGFP124stop 12 h prior to the addition of nocodazole.
Fig. 4. Localization of different RNAs in chromatoid bodies by in situ hybridization and
confocal microscopy. Squashed samples from stages V–VII mouse seminiferous tubules
were used. In situ hybridizationwas performedwith a biotin-labelled oligo(dT) probe to
detect mRNAs (A), or biotin-labelled nucleotide probes speciﬁc for 5S rRNA (B), U1
snRNA (C), 18S rRNA (D), 28S rRNA (E), or tRNA (F) (red channel). RNA molecules were
revealed with alexa633-labelled streptavidin (red). After in situ hybridization, VASA
homolog MVH signals were detected by immunoﬂuorescence (green channel), and
nuclei were stainedwith Hoechst (blue channel). Scale bar: 5 μm. Original magniﬁcation
×60.
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aggresomes since GFP-250 did not modify their intracellular distribu-
tion (Fig. 1B–D). As expected, the formation of GFP-250 aggresomes
did not alter the distribution of 18S and 28S rRNAs (Fig. 1E, F). These
results indicate that several but not all RNA molecules co-aggregate
speciﬁcally with PrP aggresomes.
3.2. Cytosolic PrP can induce the aggregation of RNA independently of
the formation of aggresomes
CyPrPEGFP co-puriﬁes with mRNAs in oligo-dT cellulose pull down
assays, strongly suggesting that PrP aggresomes are in fact poly(A)+
ribonucleoprotein complexes [20]. This hypothesis predicts that
aggregation of cyPrPEGFP should be essential for the assembly of
ribonucleoprotein complexes. In order to address this issue, we used a
mutant unable to form aggresomes, cyPrPEGFP124stop [19]. This
mutant contains the unstructured N-terminus of PrP (residues 23–
124). Strikingly, mRNAs still assembled in a large juxtanuclear
organelle in cells expressing cyPrPEGFP124stop (Fig. 1A). This observa-
tion was conﬁrmed with probes speciﬁc to 5S, U1, and tRNAs (Fig. 1B–
D). Similar to cyPrPEGFP, 18S and 28S rRNAs did not aggregate in cells
expressing cyPrPEGFP124stop (Fig. 1E, F).
In additional experiments, we expressed CyPrPEGFP124–230, a
protein construct representing the C-terminal structured domain of
PrP which forms aggresomes [19]. As expected, cells expressing
cyPrPEGFP124–230 assembled aggresomes; however, cyPrPEGFP124–
230 aggresomes did not modify the distribution of RNAs (Fig. 1). Thus,
aggregation of mRNAs, 5S rRNA and U1 snRNA is independent from
the aggregation of cyPrP. In addition, residues responsible for the
formation of this RNA organelle lie in the N-terminal domain of cyPrP.
Since the aggregation of cyPrP is not essential for the assembly of
the RNA organelle and that this organelle also contains proteins
(below), we termed this organelle PrP-induced ribonucleoprotein
particle or PrP-RNP. Several deletion mutants containing the C-
terminal domain and thus capable of forming protein aggresomes
were engineered to preciselymap the domain of PrP in the N-terminal
region that signals the formation of PrP-RNPs (Fig. 2). PrP-RNPs were
not formed in cells expressing CyPrPEGFP50-230 but assembled in cells
expressing CyPrPEGFP33–230, indicating that the aggregation deter-
minant of PrP-RNPs was located between residues 33 and 50. This was
conﬁrmed by expressing CyPrPEGFPΔ30–49, a deletion mutant missing
a domain located between residues 30 to 49. This mutant was not able
to induce the formation of PrP-RNP (Fig. 2).
3.3. PrP-RNPs share structural and functional criterions similar to
protein aggresomes
PrP-RNPs, like protein aggresomes, assemble in a juxtanuclear
area. One possibility to explain this observation would be that these
RNA organelles are in fact RNA-containing aggresomes. To test this
hypothesis, we examined four main features of protein aggresomes in
cells expressing cyPrPEGFP124stop; localization of PrP-RNPs around
the microtubule organising center or centrosome, assembly of a cage
of vimentin around PrP-RNPs, clustering of mitochondria, and the
requirement for an intact microtubule network for their assembly
[22]. As shown in Fig. 3A and B, PrP-RNPs also localized around γ-
tubulin, a component of the centrosome, and were surrounded by a
cage composed of vimentin protein. Furthermore, a major rearrange-
ment of the mitochondrial network occurred in cells expressing
cyPrPEGFP124stop. Mitochondria, which are normally distributed
throughout the cytoplasm were clustered around PrP-RNPs, leaving
no detectablemitochondria in other regions of the cytoplasm (Fig. 3C).
We also tested the effect of the microtubule-depolymerising agent
nocodazole. Nocodazole completely prevented the formation of PrP-
RNPs (Fig. 3D). Thus, besides cytological criterions examined above,
PrP-RNPs also share functional features with protein aggresomes.3.4. PrP-RNPs and RNA granules from germ cells or planarian stem cells
and neurons share similar components
To our knowledge, the only known cytoplasmic bulky RNA particle
described in the literature is large, nonmembranous, RNA-rich
organelles typically found around the nuclei of germ cells, planarian
stem cells and neurons [23,24]. Germ granules are also known under
the name of chromatoid bodies [25]. Similar to PrP-RNPs, chromatoid
bodies contain mRNAs, 5S rRNA and U1 snRNPs [26,27]. They also
display aggresomal characteristics, including a cage of vimentin
surrounding the RNA granule [28]. mRNA is the only RNA molecule
that has been detected by FISH in chromatoid bodies; the presence of
5S was detected by electrophoretic analysis of RNA extracted from
chromatoid bodies, and the presence of 18S and 28S was not sought
[26]. Furthermore, the presence of U1 was indirectly detected using
anti-U1 snRNP antibodies [27]. In order to compare the RNA
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experiments on squash preparations of mouse seminiferous tubules.
The ATP-dependent DEAD-box RNA helicase VASA/MVHwas used as a
speciﬁc marker for the chromatoid body [29,30]. The chromatoid body
was labelled with poly(A+), 5S and U1 probes (Fig. 4A–C). In contrast,
there was no concentration of 18S and 28S rRNAs in the chromatoid
body (Fig. 4D, E). Interestingly, tRNAs were also concentrated in
chromatoid bodies although some tRNA remained distributed
throughout the cytoplasm (Fig. 4F).
These data motivated us to further analyze a possible relationship
between chromatoid bodies and PrP-RNPs. Recently, several miRNAs
were shown to concentrate in chromatoid bodies, includingmiR-122a,
miR-21, and let-7a [30]. The distribution of these miRNAs was
determined by FISH using speciﬁc oligonucleotide probes in cells
expressing cyPrPEGFP and cyPrPEGFP124stop. In agreement with
previous studies, miRNAs were mostly located throughout the
cytoplasm in control untransfected cells (Fig. 5) [31,32]. The analysis
on cells expressing cyPrPEGFP revealed a high concentration of miR-
122a, miR-21, and let-7a within PrP-RNPs. miRNAs also concentrated
in a juxtanuclear area in cells expressing cyPrPEGFP124stop (Fig. 5).
Chromatoid bodies are also characterized by the accumulation of a
speciﬁc set of proteins [25]. Here, four different protein markers were
investigated in cells expressing cyPrPEGFP124stop. Similar results were
obtained in cells expressing cyPrPEGFP (not shown). First, the mRNAs
decapping Dcp1a enzyme is a component of RNA processing bodies or
P-bodies and has normally a granular cytoplasmic localization [33].
Interestingly, Dcp1a concentrate in chromatoid bodies, indicating a
functional analogy with P-bodies [30]. The granular distribution of
Dcp1a was conﬁrmed in mock-transfected cells (Fig. 6A). In sharp
contrast, Dcp1a concentrate in PrP-RNPs (Fig. 6B). Second, the DEAD
box-family RNA helicase VASA/MVH is a classical marker of chroma-
toid bodies [29,30]. VASA/MVH is speciﬁc to germinal cells and could
not be detected in N2a cells (not shown). We determined if DDX6, a
more ubiquitous DEAD box RNA helicase generally present in
messenger ribonucleoprotein particles including P-bodies and stress
granules could concentrate in PrP-RNPs [34,35]. Indeed, DDX6
accumulated in PrP-RNPs in cells expressing cyPrPEGFP124stop (Fig.
6C, D). Third, Dicer, a double-stranded RNAseIII essential for RNA
interference and the biogenesis of miRNAs was recently detected in
chromatoid bodies [30]. It was suggested that chromatoid bodies mayFig. 5.miRNAs are concentrated in PrP-RNPs. Biotin-labelled nucleotide probes speciﬁc for mi
in mock-transfected N2a cells, or cells transfected with CyPrPEGFP or CyPrPEGFP124stop (g
alexa568-labelled streptavidin (red channel). N, nucleus. Scale bar: 5 μm. Original magniﬁcaparticipate in the posttranscriptional control of gene expression
through the small RNAs pathway [30]. Remarkably, we also found
Dicer associated with PrP-RNPs (Fig. 6E, F). Finally, Sm proteins are
essential core components of small nuclear ribonucleoprotein
particles present in the spliceosome. Sm proteins are central to RNA
metabolism, and are involved in diverse processes such as pre-mRNA
splicing and telomere formation. Sm proteins also localize to the
chromatoid body [27,36]. Using an antibody recognizing the three Sm
proteins B/B′/N, Sm proteinswere also detected in PrP-RNPs (Fig. 6G, H).
In a control experiment, we veriﬁed that the concentration of
proteins in PrP-RNPs is not a general phenomenon. Previously, we
have shown that ribosomal protein S6 did not co-aggregate with
mRNA in cyPrPEGFP aggresomes [20]. Ribosomal protein S6 does not
coalesce in PrP-RNPs either but remains distributed throughout the
cytoplasm (Fig. 6I, J).
3.5. PrP-RNPs and nuclear pore complexes
One important feature of chromatoid bodies is their frequent
contacts with nuclear pore complexes [37]. In some instances, material
continuities between intranuclear dense particles and chromatoid
bodies are revealed by electron microscopy. In order to verify the
relationship between nuclear pore complexes and PrP-RNPs, nuclear
pores were immunostained using antibodies against FXFG repeat
nucleoporins, which are positioned throughout the pore complexes.
Indirect immunoﬂuorescence images combined with FISH with an
oligo-dT probe conﬁrmed the proximity between PrP-RNPs and the
nuclear envelope in cells expressing cyPrPEGFP or cyPrPEGFP124stop
(Fig. 7A). Furthermore, similar to chromatoid bodies, some FXFG
repeat nucleoporins were also present in PrP-RNPs (Fig. 7A).
An important characteristic of the chromatoid body is its move-
ments along and perpendicular to the nuclear envelope [37]. PrP-RNPs
were mainly detected close to the nuclear pore complexes, but were
also detected at a variable distance from the nuclear envelope
(compare Fig. 7A and B).
3.6. Association between vimentin and protein components of PrP-RNPs
To biochemically conﬁrm the assembly of PrP-RNPs, we attempted
to afﬁnity-purify protein components of this organelle using vimentinR-122a (A), miR-21 (B), and let-7a (C) were used to determine the distribution ofmiRNAs
reen channel), as indicated. The miRNAs were revealed by confocal microscopy with
tion ×60.
Fig. 6. Localization of Dcp1a, DDX6, Dicer, and SmB/B′/N in PrP-RNPs by confocal microscopy. PrP-RNPs (arrows) were revealed by in situ hybridizationwith a biotin-labelled o o(dT) probe to detect mRNAs (red channel) in mock-transfected
N2a cells (A, C, E, G, I) or N2a cells expressing CyPrPEGFP124stop (green channel in B, D, F, H, J). Following in situ hybridization, Dcp1a (A, B), DDX6 (C, D), Dicer (E, F), S /B′/M (G, H), and ribosomal S6 protein (I, J) were detected by
immunoﬂuorescence using speciﬁc antibodies (blue channel). n, nuclei. Arrows show PrP-RNPs. Scale bar: 5 μm. Original magniﬁcation ×60.
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Fig. 7. PrP-RNPs are proximal to the nuclear envelope and contain FXFG repeat
nucleoporins. Confocal images of PrP-RNPs revealed by in situ hybridization with a
biotin-labelled oligo(dT) probe and alexa633-labelled streptavidin to detect mRNAs
(red channel) in mock-transfected N2a cells, or in N2a cells expressing CyPrPEGFP or
CyPrPEGFP124stop, as indicated. Following in situ hybridization, FXFG repeat nucleopor-
ins (Nup) were detected by immunoﬂuorescence using speciﬁc antibodies (yellow
channel). (A) PrP-RNPs are mainly located in close contact to the nuclear envelope. (B)
PrP-RNPs may also be observed far from the nuclear envelope. (A, B) Some FXFG repeat
nucleoporins are detected within PrP-RNPs. n, nuclei. Arrows show PrP-RNPs. Scale bar:
5 μm. Original magniﬁcation ×60.
Fig. 8. Association of PrP-RNPs and vimentin. Co-immunoprecipitation experiments
with anti-vimentin antibodies were performed using mock-transfected N2a cells (lanes
1–3), or N2a cells transfected with CyPrPEGFP (lanes 4–6), CyPrPEGFP124stop (lanes 7–
10), CyPrPEGFP124–230 (lanes 11–13), or GFP-250 (lanes 14–16). Lanes 1, 4, 7, 11, 14 show
Dicer, Dcp1, DDX6, and SmB/B′/N in 5% of total cell lysate. Lanes 2, 5, 8, 12, and 15 show
afﬁnity-puriﬁed Dicer, Dcp1, DDX6, and SmB/B′/N using isotype control antibodies.
Lanes 3, 6, 8, 13, and 16 show afﬁnity-puriﬁed Dicer, Dcp1, DDX6, and SmB/B′/N using
anti-vimentin antibodies. Molecular weight markers in kDa are indicated on the right.
This experiment is representative of three independent experiments.
Fig. 9. Cytoplasmic localization of endogenous PrP in germ cells containing a
chromatoid body. Confocal images of squashed samples from pachitene stage (before
second meiosis, A) and haploid stage (B) of mouse seminiferous tubules. Squashed
samples are ﬁxed and permeabilized. In situ hybridizationwas performed with a biotin-
labelled oligo(dT) probe to detect mRNAs. mRNAswere revealed with alexa633-labelled
streptavidin (red). After in situ hybridization, endogenous PrP signals were detected by
immunoﬂuorescence (SAF32 antibody, green channel), and nuclei were stained with
Hoechst (blue channel). PrP was not detected at the plasma membrane in cells from
haploid stages (B). Scale bar: 5 μm. Original magniﬁcation ×60.
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from cells expressing cyPrPEGFP or cyPrPEGFP124stop contained Dcp1a,
DDX6, Dicer, and Sm (Fig. 8, lanes 6, 10). In contrast, these proteins did
not purify with anti-vimentin antibodies in mock-transfected cells,
conﬁrming the speciﬁcity of this association in cells with PrP-RNPs
(Fig. 8, lane 3). We consistently observed some association between
vimentin and Dcp1a. However, this association was largely increased
in cells expressing cyPrPEGFP or cyPrPEGFP124stop (Fig. 8). Isotype
control antibody did not immunoprecipitate Dcp1a, DDX6, Dicer, and
SmB/B′/N, again conﬁrming the speciﬁcity of this interaction (Fig. 8,
lanes 5, 8). Furthermore, anti-vimentin antibodies did not purify
Dcp1a, DDX6, Dicer, and SmB/B′/N in cells expressing CyPrPEGFP124–
230 (lanes 11–13), or GFP-250 (14–16).
3.7. PrP is detected in the cytoplasm of mouse germ cells displaying a
chromatoid body
Chromatoid bodies are absent in spermatocytes before the second
meiosis of spermatogenesis, and are visible in round spermatidsduring the haploid phase of spermatogenesis [37]. They disappear
with the residual body during late spermatogenesis. In order to test
the hypothesis that endogenous PrP may be present in the cytoplasm
of round spermatids, we analyzed the distribution of PrP in germ cells
before the second meiosis and during the haploid phase in squash
preparations of mouse seminiferous tubules (Fig. 9). PrP is mainly
located at the plasma membrane in spermatocytes (Fig. 9A). In
contrast, PrP has a cytoplasmic distribution in round spermatids
containing a chromatoid body (Fig. 9B).
4. Discussion
The presence of PrP in the cytosol has been detected in a
subpopulation of neurons and in beta-pancreatic cells [9,10]. A recent
study described a new GPI-anchorless splice variant of the prion
344 S. Beaudoin et al. / Biochimica et Biophysica Acta 1793 (2009) 335–345protein in human brain and non-neuronal tissues [11]. Interestingly,
this variant is located in the cytosol and its levels increase in hypoxic
conditions in a human glioblastoma cell line. Altogether, these results
point to a possible function of PrP in the cytoplasm. Yet, whether PrP
has a speciﬁc function in this location and what this function might be
has remained elusive. Our ﬁndings support a scenario where cyPrP
induces the assembly of an RNA processing center similar to RNA
granules termed chromatoid bodies.
4.1. cyPrP induces the assembly of a large ribonucleoprotein particle
termed PrP-RNP
An important result of this study is the observation that cyPrP
induces the formation of an RNA organelle termed PrP-RNP. We have
also observed PrP-RNPs in several neuronal and non-neuronal cells
from murine and human origin. In this manuscript, only results
obtained in N2a cells are shown for clarity reasons. The composition of
PrP-RNPs is not speciﬁc to one class of RNA but includes several types
of RNA molecules. These results seem to be in accordance with
previous in vitro studies describing the nucleic-acid binding activity of
recombinant PrP [38]. If co-aggregation of cyPrP and RNA is a
consequence of a direct interaction between these two macromole-
cules, a strict correlation should be expected between cyPrP aggrega-
tion and the assembly of PrP-RNPs. Hence, aggregation of cyPrP
should be essential for the assembly of PrP-RNPs. However, expression
of several deletion mutants demonstrates that aggregation of cyPrP
and RNA can be uncoupled. Similar to PrP aggresomes, PrP-RNPs
induced by a cyPrP mutant unable to aggregate deposit at the
centrosome, are surrounded by a cage of vimentin, and their assembly
is dependent on a functional microtubule network. Thus, cyPrP and
PrP-RNPs co-aggregate for the reason that they utilize the same
aggresomal pathway.
These results are signiﬁcant in terms of the molecular activity of
cyPrP. They show that in the cytosol, PrP activates an aggresomal
pathway responsible for the biogenesis of PrP-RNPs. This activity is
independent from cyPrP aggregation and therefore, does not require a
direct contact between cyPrP and RNA in the PrP-RNP. However, the
possibility that an interaction between cyPrP and a speciﬁc RNA
molecule may be responsible for the induction of PrP-RNPs cannot be
ruled out. In favour of this hypothesis, the domain involved in the
assembly of PrP-RNPs is located between residues 30 and 50;
interestingly, this domain also binds RNA in vitro [39].
4.2. PrP-RNPs are similar to chromatoid bodies
Although several types of RNAs concentrate in PrP-RNPs, the
observation that cyPrP does notmodify the distribution of 18S and 28S
rRNAs indicates some speciﬁcity and regulation in the mechanism of
assembly of PrP-RNPs. Several lines of evidence suggest that PrP-RNPs
are similar to previously described RNA granules also known as
chromatoid bodies from germ cells, or from planarian stem cells and
neurons [25,36]. First, both organelles concentrate identical RNA
molecules. We used FISH to conﬁrm the presence of mRNA, snU1RNA,
5S rRNA, and several miRNAs in spermatid cells and in PrP-RNPs. We
could also detect tRNAs in these RNA granules. Second, proteins
involved in different steps of the metabolism of RNA and that
accumulate in chromatoid bodies also concentrate in PrP-RNPs. Third,
like chromatoid bodies, PrP-RNPs share similar aggresomal character-
istics. Fourth, similar to chromatoid bodies, PrP-RNPs are proximal to
nucleoporins. Fifth, endogenous PrP is present in the cytoplasm of
round spermatids containing chromatoid bodies. Despite these
characteristics, the possibility that PrP-RNPs and chromatoid bodies
are different organelles cannot be completely excluded.
It has become generally accepted that assembly of the chromatoid
body constitutes a mechanism of centralising the post-transcriptional
processing and storage of various RNA species [40]. Yet, its speciﬁcfunction has remained elusive for decades. One possible function is
related to the pluripotency of stem cells and germ cells. Planarians are
notorious for their strong regenerative ability. This exceptional
property is considered to reside in speciﬁc stem cells termed neoblast
that contain a chromatoid body [24]. The chromatoid body is also
predicted to give germ cells the ability to differentiate while
maintaining a totipotent genome [25]. Interestingly, PrP is a marker
for hematopoietic stem cells and supports their self-renewal [41]. In
addition, PrP positively regulates the proliferation of neural precursors
during developmental and adult mammalian neurogenesis [42]. It
would be interesting to determine if this proliferation activity of PrP
depends on the formation of PrP-RNPs.
PrP-RNPs, like chromatoidbodies share componentswith cytoplasmic
foci termed P bodies where untranslated mRNAs accumulate, awaiting
translational reactivation or degradation (Anderson and Kedersha, 2006;
Seydoux and Braun, 2006). These components include Dcp1a, and
microRNAs. A complete list of molecules for any of these granules is not
yet available. Such a list would be essential to determine the relationship
between these RNA granules. Although these RNA granules may have a
very similar composition, the juxtanuclear localization of PrP-RNPs and
chromatoid bodies is speciﬁc. Thus, the function of PrP-RNPs and
chromatoid bodies is also likely different from the function of P bodies.
4.3. PrP and the RNA connection
It iswell established thatPrPhas nucleic-acidbindingactivity invitro
[43]. In some instances, PrP exhibits RNAchaperoneproperties similar to
the nucleoprotein NCP7 of HIV-1, and to the nucleoprotein of feline
immunodeﬁciency virus [44, 45]. Reciprocally, binding of recombinant
or puriﬁed PrP to RNA in vitro induces profound conformational
rearrangements and results in a protease-K resistant (PrPRes) isoform
[46–49]. Furthermore, RNA molecules co-localize with large extracel-
lular hamster prions aggregates in infected hamsters [50]. Thus, it is
tempting to propose that interactions between RNA and PrP may be a
facilitating if not an essential factor in the conversion of PrP into PrPRes.
Our results reveal a novel dimension in the relation between PrP
and RNA in vivo. Indeed, a simple interaction of PrP with mRNAs, 5S
rRNA, U1 snRNA, tRNA, and several miRNAs, but not with 18S and 28S
rRNAs would hardly explain how these RNAs and several proteins
involved in the life and death of RNA are speciﬁcally concentrated in a
large ribonucleoprotein particle. We suggest that a new signalling
mechanism between PrP and RNA remains to be discovered.
In summary, the discovery of PrP-RNPs should prove to be
extremely useful for better understanding the biological relevance of
cytoplasmic PrP.
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